These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25731725)

  • 21. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholipid Type Regulates Protein Corona Composition and
    Pan F; Liu M; Li G; Chen B; Chu Y; Yang Y; Wu E; Yu Y; Lin S; Ding T; Wei X; Zhan C; Qian J
    Mol Pharm; 2024 May; 21(5):2272-2283. PubMed ID: 38607681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biomolecular corona of nanoparticles in circulating biological media.
    Pozzi D; Caracciolo G; Digiacomo L; Colapicchioni V; Palchetti S; Capriotti AL; Cavaliere C; Zenezini Chiozzi R; Puglisi A; Laganà A
    Nanoscale; 2015 Sep; 7(33):13958-66. PubMed ID: 26222625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological effects of formation of protein corona onto nanoparticles.
    Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
    Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive analysis of liposomal biomolecular corona upon human plasma incubation: The evolution towards the lipid corona.
    La Barbera G; Capriotti AL; Caracciolo G; Cavaliere C; Cerrato A; Montone CM; Piovesana S; Pozzi D; Quagliarini E; Laganà A
    Talanta; 2020 Mar; 209():120487. PubMed ID: 31892008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.
    Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.
    Lima T; Bernfur K; Vilanova M; Cedervall T
    Sci Rep; 2020 Jan; 10(1):1129. PubMed ID: 31980686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids.
    Papafilippou L; Nicolaou A; Kendall AC; Camacho-Muñoz D; Hadjidemetriou M
    Nanoscale; 2023 Jul; 15(26):11038-11051. PubMed ID: 37357917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages.
    Shaw CA; Mortimer GM; Deng ZJ; Carter ES; Connell SP; Miller MR; Duffin R; Newby DE; Hadoke PW; Minchin RF
    Nanotoxicology; 2016 Sep; 10(7):981-91. PubMed ID: 27027807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.
    Lundqvist M; Stigler J; Elia G; Lynch I; Cedervall T; Dawson KA
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14265-70. PubMed ID: 18809927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.
    Arcella A; Palchetti S; Digiacomo L; Pozzi D; Capriotti AL; Frati L; Oliva MA; Tsaouli G; Rota R; Screpanti I; Mahmoudi M; Caracciolo G
    ACS Chem Neurosci; 2018 Dec; 9(12):3166-3174. PubMed ID: 30015470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
    Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation methods commonly used to study the liposomal protein corona suffer from contamination issues.
    Kristensen K; Münter R; Kempen PJ; Thomsen ME; Stensballe A; Andresen TL
    Acta Biomater; 2021 Aug; 130():460-472. PubMed ID: 34116227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer.
    Capriotti AL; Caracciolo G; Caruso G; Cavaliere C; Pozzi D; Samperi R; Laganà A
    Anal Bioanal Chem; 2010 Dec; 398(7-8):2895-903. PubMed ID: 20859620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Protein Source on Liposome Uptake by Cells: Corona Composition and Impact of the Excess Free Proteins.
    Yang K; Reker-Smit C; Stuart MCA; Salvati A
    Adv Healthc Mater; 2021 Jul; 10(14):e2100370. PubMed ID: 34050634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of Lipid Corona Formation on Colloidal Nanoparticles from Lipid Vesicles.
    Zhang X; Pandiakumar AK; Hamers RJ; Murphy CJ
    Anal Chem; 2018 Dec; 90(24):14387-14394. PubMed ID: 30427176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles.
    Partikel K; Korte R; Mulac D; Humpf HU; Langer K
    Beilstein J Nanotechnol; 2019; 10():1002-1015. PubMed ID: 31165027
    [No Abstract]   [Full Text] [Related]  

  • 40. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.